Do you feel that in the air? No, it’s not just the sting of the cold winds on your face. It’s love, which means it’s almost ...
ZELVYSIA is anticipated to launch in March 2026, shortly following the introduction of PYQUVI. Together, these launches represent a significant step forward in Aucta Pharmaceuticals’ branded generic ...
Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL.  PYQUVI, a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) ...